Trial reportPsychology and aging2025
Testing the purported mechanisms of the AgingPLUS intervention: Effects on physical activity outcomes.
Trial report in Psychology and aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Personal and General Views on Aging, Non-Communicable Diseases, and Their Interaction as Cross-Sectional Correlates of Vigorous Physical Activity in UK Individuals Aged 50.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Following the experimental medicine approach, Diehl et al. (2023) demonstrated the malleability of negative views of aging (NVOA), self-efficacy beliefs, and exercise intention in middle-aged and older adults who participated in the AgingPLUS intervention program. The present study built on those findings and addressed (a) whether the intervention resulted in significant improvements in physical activity (PA) and (b) whether the purported mechanistic variables were significant mediators of the intervention's effects on PA outcomes. AgingPLUS used a randomized, single-blind control group design to implement the intervention in a sample of 335 adults aged 45-75 years. This study reports findings from 278 participants (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.